Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 80/100

Becton Dickinson and Co at Jefferies Virtual London Healthcare Conference Transcript

Nov 18, 2020 / 12:55PM GMT
Release Date Price: $227.62 (-3.69%)
Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Thanks, everyone, again for joining us here at the Jefferies 2020 Virtual London Healthcare Conference. I'm Raj Denhoy with the medical device research team. Along with me today, we have Anthony Petrone and Brandon Couillard also from Jefferies.

And our next presentation is from Becton, Dickinson. And from the company, we have Tom Polen, the company's CEO; Chris Reidy, the company's CFO. And we also have Kristen Stewart. And I think Kristen is going to start us off with a brief statement, and then we'll get into Q&A.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Thanks, everyone, for joining us. Just as a reminder, today's discussion may make some forward-looking statements. It is possible that actual results could differ from our expectations. In particular, there continues to be uncertainty about the duration and contemplated impact of the COVID-19 pandemic. Risks, uncertainties and other factors that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot